CHERRY Aktie 112129002 / DE000A3CRRN9
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
12.08.2025 08:59:03
|
EQS-News: Cherry SE: CHERRY Digital Health Receives Provider Approval for TI Messenger
|
EQS-News: CHERRY SE
/ Key word(s): Regulatory Approval
Munich, 12 August 2025 – CHERRY Digital Health has reached another important milestone: The company has received official provider approval for the TI Messenger from gematik. This approval marks a decisive step in CHERRY’s efforts to offer innovative solutions for the digitalization of healthcare. The CHERRY TI Messenger enables secure, GDPR-compliant, and cross-sector communication in the healthcare sector. Medical professionals can now communicate in real time, exchange findings and ask questions about medications — all via a single, user-friendly platform that can be used on both computers and smartphones. This allows flexible, device-independent use, significantly simplifying communication in healthcare. Why is the TI Messenger needed? Currently, many healthcare providers still rely on fax, telephone, and analog communication channels. The TI Messenger offers a modern, digital alternative that meets the highest security standards and significantly increases communication efficiency. Unlike conventional messaging services like WhatsApp, the TI Messenger complies fully with GDPR requirements and is approved by gematik. This ensures the highest security standards for sensitive medical data and promotes collaboration across different healthcare sectors. Additionally, the TI Messenger is continuously being further developed. By the end of the third quarter, TI-M Pro will be available, enabling communication with patients and health insurance providers as well. Dr. Philip Groth, Managing Director of CHERRY Digital Health, comments: " The provider approval by gematik confirms the quality and security of our TI Messenger solution. We are now ready to enter the market together with our partners and make a significant contribution to the digitalization of healthcare. Our goal is to make communication in the healthcare sector more efficient, secure, and user-friendly." Key advantages of the CHERRY TI Messenger:
CHERRY TI Messenger is based on innovative technology from Awesome Technologies and was developed specifically for the needs of the German healthcare system. It complements the CHERRY Digital Health portfolio. With this provider approval, CHERRY Digital Health underlines its position as a leading provider of health technologies and a reliable partner for all stakeholders in healthcare. For more information about the CHERRY TI Messenger, please click here.
About CHERRY Digital Health CHERRY Digital Health is a leading provider of health technologies. With innovative products such as readers for health cards, hygiene keyboards and its own SaaS solution, the company sets new standards in the equipment of clinics, practices and pharmacies. Through close cooperation with hospitals, doctors' practices and medical professionals, CHERRY Digital Health ensures the highest standards and customer-oriented solutions. Certified quality and continuous development make CHERRY Digital Health a reliable partner for all players in the healthcare sector.
PRESS CONTACT Lauren Sawyer CHERRY Press Team
PRESSEKONTAKT Claire Dove CHERRY Presseteam cherry@piabo.net
12.08.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Cherry SE |
| Rosental 7, c/o Mindspace | |
| 80331 Munich | |
| Germany | |
| ISIN: | DE000A3CRRN9 |
| WKN: | A3CRRN |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2182490 |
| End of News | EQS News Service |
|
|
2182490 12.08.2025 CET/CEST
Nachrichten zu CHERRY
Wird Europa von Innovation abgehängt? KI, Industrie & Wachstumstreiber im Fokus | BX Swiss TV
Hat Europa im globalen Innovationswettlauf noch eine Chance? 🚀
Im Experteninterview spricht Evelyne Pflugi, CEO & Mitgründerin der Singularity Group, mit David Kunz (COO der BX Swiss) über die Innovationskraft Europas, den Umgang mit geopolitischen Risiken und die wahren Wachstumstreiber der Weltwirtschaft.
Themen im Video:
🔹 Wie innovativ ist Europa wirklich – im Vergleich zu USA und Asien?
🔹 Warum The Singularity Group auf profitables Wachstum statt Hypes setzt
🔹 KI, Big Data, Cloud – aber auch Kühlung & Energie: Wo entsteht echter Mehrwert?
🔹 Was unterscheidet erfolgreiche Fondsmanager von der breiten Masse?
🔹 Warum SAPs Wachstum Amazon mehr nützt als Europa selbst
🔹 Branchen-Favoriten: Data Center, Energie-Infrastruktur, Automatisierung
🔹 Wachstum ohne Blase: KI, ja – aber nicht jede Anwendung ist investierbar
Inside Trading & Investment
Mini-Futures auf SMI
Aktien in diesem Artikel
| CHERRY | 0.59 | 1.03% |
|
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Nach Fed-Zinssenkung: SMI etwas fester -- DAX schwächelt -- Asiens Börsen schliessen überwiegend in RotDer heimische Aktienmarkt präsentiert sich zum Wochenschluss höher, während sich der deutsche Leitindex etwas nachgibts. Am Freitag gingen die führenden Börsen Asiens nach der Fed-Zinssenkung mehrheitlich schwächer aus dem Handel.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |